Bleday R, Wong W D
Harvard Medical School, New England Deaconess Hospital, Boston, Massachusetts.
Curr Probl Cancer. 1993 Jan-Feb;17(1):1-65. doi: 10.1016/0147-0272(93)90003-k.
Surgery is the mainstay of therapy for colon and rectal cancer. Over the past several decades, there have been important advances both in the understanding of the biology of colon and rectal cancer and in the preoperative and operative techniques for treating this disease. Although it appears in some studies that we have made a difference in the survival rates in the treatment of colon and rectal cancer, in actual fact, this phenomenon may only be secondary to better staging and, therefore, a greater ability to prognosticate a particular patient's chance of cure. What has been learned in the past 20 to 30 years is that most colon and rectal carcinomas start as polyps of the colon and rectum. Most often, polyps are sporadic, but there are certain high-risk groups that produce polyps and, consequently, colon and rectal cancer at a much higher rate. The goal of a practicing physician is to identify these high-risk individuals and to recommend frequent screenings so as to intervene before a polyp has had a chance to become a deeply invasive cancer. These high-risk groups are best typified by familial adenomatous polyposis, which if left untreated will, in 100% of cases, lead to the death of a patient from colon or rectal cancer. Other diseases that lead to an increase in colon and rectal cancer but may not go through the usual adenoma-to-carcinoma sequence include inflammatory bowel disease such as Crohn's colitis and ulcerative colitis. Most patients with colorectal carcinoma are asymptomatic at the time of diagnosis. This phenomenon has led to efforts to screen the general population for polyps and for cancer. Screening techniques such as the detection of occult blood in the stool and endoscopic procedures are currently the most popular. It is unclear at this time exactly what the efficacy of these techniques is in improving the survival of the general population from colorectal carcinoma. The surgical techniques to remove colon and rectal carcinomas have recently expanded to include a more aggressive local excision policy for small tumors of the rectum and the application of laparoscopic techniques, new stapling techniques, and new anastomosing techniques for tumors of the colon and rectum. These techniques have become possible in part through advances in surgical instrumentation and also in part from our increasing understanding of the biology of the disease. Both have allowed for more creative approaches to diagnosing and treating colon and rectal cancer.(ABSTRACT TRUNCATED AT 400 WORDS)
手术是结肠癌和直肠癌治疗的主要手段。在过去几十年里,人们对结肠癌和直肠癌生物学的认识以及治疗该病的术前和手术技术都取得了重要进展。尽管在一些研究中似乎我们在结肠癌和直肠癌的治疗生存率方面有了改善,但实际上,这种现象可能只是由于更好的分期,因此,有更强的能力预测特定患者的治愈机会。在过去二三十年里所了解到的是,大多数结肠癌和直肠癌起源于结肠和直肠息肉。大多数情况下,息肉是散发性的,但有某些高危群体息肉的发生率更高,因此患结肠癌和直肠癌的几率也更高。执业医师的目标是识别这些高危个体,并建议他们频繁进行筛查,以便在息肉有机会发展成深度浸润性癌症之前进行干预。这些高危群体中最典型的是家族性腺瘤性息肉病,如果不治疗,100%的患者会死于结肠癌或直肠癌。其他导致结肠癌和直肠癌发病率增加但可能不经过通常的腺瘤到癌序列的疾病包括炎症性肠病,如克罗恩结肠炎和溃疡性结肠炎。大多数结直肠癌患者在诊断时没有症状。这种现象促使人们努力对普通人群进行息肉和癌症筛查。目前,诸如粪便潜血检测和内镜检查等筛查技术最为常用。目前尚不清楚这些技术在提高普通人群结直肠癌生存率方面的确切效果。切除结肠癌和直肠癌的手术技术最近有所扩展,包括对直肠小肿瘤采取更积极的局部切除策略,以及对结肠和直肠肿瘤应用腹腔镜技术、新的吻合器技术和新的吻合技术。这些技术的实现部分得益于手术器械的进步,也部分得益于我们对该疾病生物学认识的不断加深。这两者都使得在诊断和治疗结肠癌和直肠癌方面有了更具创造性的方法。(摘要截选至400词)